Evidence map›Paper›PMID 35653170›Full record

ArticleJMIR medical informatics2022

Predicting 30-Day Readmission Risk for Patients With Chronic Obstructive Pulmonary Disease Through a Federated Machine Learning Architecture on Findable, Accessible, Interoperable, and Reusable (FAIR) Data: Development and Validation Study.

Celia Alvarez-Romero, Alicia Martinez-Garcia, Jara Ternero Vega, Pablo Díaz-Jimènez, Carlos Jimènez-Juan, María Dolores Nieto-Martín, Esther Román Villarán, Tomi Kovacevic, Darijo Bokan, Sanja Hromis and 7 more

Open access · goldAbstract read
In one paragraph

Article in JMIR medical informatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 3 countries.

Celia Alvarez-RomeroComputational Health Informatics Group, Institute of Biomedicine of Seville, Virgen del Rocío University Hospital, Consejo Superior de Investigaciones Científicas, University of Seville, Seville, Spain.ORCID https://orcid.org/0000-0001-8647-9515
Alicia Martinez-GarciaComputational Health Informatics Group, Institute of Biomedicine of Seville, Virgen del Rocío University Hospital, Consejo Superior de Investigaciones Científicas, University of Seville, Seville, Spain.ORCID https://orcid.org/0000-0001-5614-7747
Jara Ternero VegaInternal Medicine Department, Virgen del Rocío University Hospital, Seville, Spain.ORCID https://orcid.org/0000-0002-3978-3079
Pablo Díaz-JimènezInternal Medicine Department, Virgen del Rocío University Hospital, Seville, Spain.ORCID https://orcid.org/0000-0002-0539-2942
Carlos Jimènez-JuanInternal Medicine Department, Virgen del Rocío University Hospital, Seville, Spain.ORCID https://orcid.org/0000-0002-7389-4151
María Dolores Nieto-MartínInternal Medicine Department, Virgen del Rocío University Hospital, Seville, Spain.ORCID https://orcid.org/0000-0002-8488-2279
Esther Román VillaránComputational Health Informatics Group, Institute of Biomedicine of Seville, Virgen del Rocío University Hospital, Consejo Superior de Investigaciones Científicas, University of Seville, Seville, Spain.ORCID https://orcid.org/0000-0001-8360-4704
Tomi KovacevicInstitute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, .ORCID https://orcid.org/0000-0002-2903-5261
Darijo BokanInstitute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, .ORCID https://orcid.org/0000-0002-0422-3071
Sanja HromisInstitute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, .ORCID https://orcid.org/0000-0001-6132-1551
Jelena Djekic MalbasaInstitute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, .ORCID https://orcid.org/0000-0003-4936-2670
Suzana BeslaćInstitute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, .ORCID https://orcid.org/0000-0001-7452-0066
Bojan ZaricInstitute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, .ORCID https://orcid.org/0000-0003-3215-8390
Mert GencturkSoftware Research & Development and Consultancy Corporation, Ankara, Turkey.ORCID https://orcid.org/0000-0003-2697-5722
A Anil SinaciSoftware Research & Development and Consultancy Corporation, Ankara, Turkey.ORCID https://orcid.org/0000-0003-4397-3382
Manuel Ollero BaturoneInternal Medicine Department, Virgen del Rocío University Hospital, Seville, Spain.ORCID https://orcid.org/0000-0003-4648-1826
Carlos Luis Parra CalderónComputational Health Informatics Group, Institute of Biomedicine of Seville, Virgen del Rocío University Hospital, Consejo Superior de Investigaciones Científicas, University of Seville, Seville, Spain.ORCID https://orcid.org/0000-0003-2609-575X
Hospital Universitario Virgen del Rocío · ESInstituto de Biomedicina de Sevilla · ESUniversity of Novi Sad · RSInstitute for Pulmonary Diseases of Vojvodina · RSSoftware Research and Development Consulting · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOwing to the nature of health data, their sharing and reuse for research are limited by legal, technical, and ethical implications. In this sense, to address that challenge and facilitate and promote the discovery of scientific knowledge, the Findable, Accessible, Interoperable, and Reusable (FAIR) principles help organizations to share research data in a secure, appropriate, and useful way for other researchers.

objectiveThe objective of this study was the FAIRification of existing health research data sets and applying a federated machine learning architecture on top of the FAIRified data sets of different health research performing organizations. The entire FAIR4Health solution was validated through the assessment of a federated model for real-time prediction of 30-day readmission risk in patients with chronic obstructive pulmonary disease (COPD).

methodsThe application of the FAIR principles on health research data sets in 3 different health care settings enabled a retrospective multicenter study for the development of specific federated machine learning models for the early prediction of 30-day readmission risk in patients with COPD. This predictive model was generated upon the FAIR4Health platform. Finally, an observational prospective study with 30 days follow-up was conducted in 2 health care centers from different countries. The same inclusion and exclusion criteria were used in both retrospective and prospective studies.

resultsClinical validation was demonstrated through the implementation of federated machine learning models on top of the FAIRified data sets from different health research performing organizations. The federated model for predicting the 30-day hospital readmission risk was trained using retrospective data from 4.944 patients with COPD. The assessment of the predictive model was performed using the data of 100 recruited (22 from Spain and 78 from Serbia) out of 2070 observed (records viewed) patients during the observational prospective study, which was executed from April 2021 to September 2021. Significant accuracy (0.98) and precision (0.25) of the predictive model generated upon the FAIR4Health platform were observed. Therefore, the generated prediction of 30-day readmission risk was confirmed in 87% (87/100) of cases.

conclusionsImplementing a FAIR data policy in health research performing organizations to facilitate data sharing and reuse is relevant and needed, following the discovery, access, integration, and analysis of health research data. The FAIR4Health project proposes a technological solution in the health domain to facilitate alignment with the FAIR principles.

Indexed as

chronic obstructive pulmonary diseaseclinical validationearly predictive modelFAIR principlesprivacy-preserving distributed data miningresearch data management

Identifiers

PMID35653170
PMCPMC9204581
OpenAlexW4225822796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.